Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)

HKG:1877 Revenue

Shanghai Junshi Biosciences had revenue of 817.20M CNY in the quarter ending September 30, 2026, with 28.19% growth. This brings the company's total for the last twelve months to 3.21B, up 29.12% year-over-year. In the year 2025, Shanghai Junshi Biosciences had annual revenue of 2.50B with 28.23% growth. That makes Shanghai Junshi Biosciences the 11,551st largest company in the world by revenue and 692nd in Hong Kong.

• Revenue (ttm): 3.21B CNY
• Revenue Growth: +29.12%
• P/S Ratio: 8.52
• Revenue / Employee: 1.05M CNY
• Employees: 3,055
• Market Cap: 32.38B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue by Geography

Chart

• China 2.27B 92.3%
• Overseas 188.80M 7.7%

Fiscal year ended Dec 31, 2025 See the full HKG:1877 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.50B	550.10M	28.23%
Dec 31, 2024	1.95B	445.77M	29.67%
Dec 31, 2023	1.50B	49.06M	3.38%
Dec 31, 2022	1.45B	-2.57B	-63.89%
Dec 31, 2021	4.02B	2.43B	152.36%

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error